NEEL SHAH, M.D.
Hematology & Oncology Physician · DYER, IN
Individual Active NPI 1356508915
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 925 | 304,284 | $26,071,317 | $7,316,307 | $5,852,504 |
| 2023 | 879 | 331,956 | $28,250,314 | $8,112,491 | $6,485,920 |
| 2022 | 885 | 346,489 | $25,309,343 | $7,110,131 | $5,688,480 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 29,600 | $56 | $44 |
| J9119 | Injection, cemiplimab-rwlc, 1 mg | 28,350 | $27 | $22 |
| J0185 | Injection, aprepitant, 1 mg | 20,540 | $2 | $1 |
| J9025 | Injection, azacitidine, 1 mg | 14,400 | $0 | $0 |
| J9263 | Injection, oxaliplatin, 0.5 mg | 13,900 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 10,680 | $26 | $21 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 8,535 | $3 | $2 |
| J9267 | Injection, paclitaxel, 1 mg | 7,848 | $0 | $0 |
| J1449 | Injection, eflapegrastim-xnst, 0.1 mg | 6,336 | $26 | $21 |
| Q5129 | Injection, bevacizumab-adcd (vegzelma), biosimilar, 10 mg | 5,313 | $64 | $51 |
| J1437 | Injection, ferric derisomaltose, 10 mg | 5,200 | $20 | $16 |
| J1756 | Injection, iron sucrose, 1 mg | 5,200 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Hematology & Oncology Physician | 207RH0003X | ✓ | 01074186A | IN |
| Hematology & Oncology Physician | 207RH0003X | 036116635 | IL |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Hematology & Oncology Physician providers in Indiana
- NPI 1528294998
- NPI 1063691830
- NPI 1619210143
- NPI 1356514608
- NPI 1598342800
- NPI 1912977281
- NPI 1861525560
- NPI 1558364372
See all Hematology & Oncology Physician providers in Indiana →
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.